ORF6 is a SARS-2 protein that shuts down traffic between the nucleus & cytoplasm in host cells, inhibiting host mRNA export & immune responses.
But in all variants since early 2023, ORF6's abilities are hampered by the ORF6:D61L mutation.
Two newish ORF6 observations....
1/15
But in all variants since early 2023, ORF6's abilities are hampered by the ORF6:D61L mutation.
Two newish ORF6 observations....
1/15
July 16, 2026 at 3:55 PM
ORF6 is a SARS-2 protein that shuts down traffic between the nucleus & cytoplasm in host cells, inhibiting host mRNA export & immune responses.
But in all variants since early 2023, ORF6's abilities are hampered by the ORF6:D61L mutation.
Two newish ORF6 observations....
1/15
But in all variants since early 2023, ORF6's abilities are hampered by the ORF6:D61L mutation.
Two newish ORF6 observations....
1/15
Eine neue Preprint-Studie zeigt, dass das SARS-CoV-2-Protein Orf6 menschliche Neuronen direkt tötet. Durch Nekroptose - eine Art des Zelltods, bei dem Neuronen platzen und Entzündungen begünstigen. Dies könnte den langfristigen Gehirnsymptomen von Long COVID zugrunde liegen.🧵
September 10, 2025 at 9:32 PM
Eine neue Preprint-Studie zeigt, dass das SARS-CoV-2-Protein Orf6 menschliche Neuronen direkt tötet. Durch Nekroptose - eine Art des Zelltods, bei dem Neuronen platzen und Entzündungen begünstigen. Dies könnte den langfristigen Gehirnsymptomen von Long COVID zugrunde liegen.🧵
Neurodegeneration und tragen zu den wachsenden Beweisen bei, die direkte virale Effekte in der Ätiologie von Neuro-PASC nahelegen.
In primären menschlichen Neuronen aktiviert Orf6 selektiv den nekrototischen Signalweg, indem es die Phosphorylierung von RIPK3 und MLKL induziert,
In primären menschlichen Neuronen aktiviert Orf6 selektiv den nekrototischen Signalweg, indem es die Phosphorylierung von RIPK3 und MLKL induziert,
September 10, 2025 at 9:37 PM
Neurodegeneration und tragen zu den wachsenden Beweisen bei, die direkte virale Effekte in der Ätiologie von Neuro-PASC nahelegen.
In primären menschlichen Neuronen aktiviert Orf6 selektiv den nekrototischen Signalweg, indem es die Phosphorylierung von RIPK3 und MLKL induziert,
In primären menschlichen Neuronen aktiviert Orf6 selektiv den nekrototischen Signalweg, indem es die Phosphorylierung von RIPK3 und MLKL induziert,
BA.4 & BA.5 emerged at the same time with identical spikes, yet BA.5 easily trounced BA.4.
I've long thought there were 2 major reasons for this: ORF1a:∆141-143 & ORF6:D61L.
ORF6:D61L impairs ORF6's ability to shut down nucleus-cytoplasm traffic. 6/10
www.cell.com/cell-host-mi...
I've long thought there were 2 major reasons for this: ORF1a:∆141-143 & ORF6:D61L.
ORF6:D61L impairs ORF6's ability to shut down nucleus-cytoplasm traffic. 6/10
www.cell.com/cell-host-mi...
June 29, 2025 at 4:46 PM
BA.4 & BA.5 emerged at the same time with identical spikes, yet BA.5 easily trounced BA.4.
I've long thought there were 2 major reasons for this: ORF1a:∆141-143 & ORF6:D61L.
ORF6:D61L impairs ORF6's ability to shut down nucleus-cytoplasm traffic. 6/10
www.cell.com/cell-host-mi...
I've long thought there were 2 major reasons for this: ORF1a:∆141-143 & ORF6:D61L.
ORF6:D61L impairs ORF6's ability to shut down nucleus-cytoplasm traffic. 6/10
www.cell.com/cell-host-mi...
ORF6 is only 61 AA long, but its primary known function (shutting down nucleus-cytoplasm trafficking) is mediated by its C-terminal domain (i.e. the last few AA). This stop codon slices off those AA. This is the last variant I ever expected to see an ORF6 loss-of-function mutant in. Weird. 3/3
January 15, 2026 at 11:36 PM
ORF6 is only 61 AA long, but its primary known function (shutting down nucleus-cytoplasm trafficking) is mediated by its C-terminal domain (i.e. the last few AA). This stop codon slices off those AA. This is the last variant I ever expected to see an ORF6 loss-of-function mutant in. Weird. 3/3
ORF6:P57S is in 40 chronic sequences, and 39 of those have ORF6:D61L—a 97.5% rate. For comparison, 44.2% of all chronics have ORF6:D61L. I think this is likely a compensatory mutation that restores ORF6's ability to shut down nucleocytoplasmic trafficking & inhibit innate immune responses.
13/15
13/15
July 16, 2026 at 3:55 PM
ORF6:P57S is in 40 chronic sequences, and 39 of those have ORF6:D61L—a 97.5% rate. For comparison, 44.2% of all chronics have ORF6:D61L. I think this is likely a compensatory mutation that restores ORF6's ability to shut down nucleocytoplasmic trafficking & inhibit innate immune responses.
13/15
13/15
So if ORF6:D61L is a harmful mutation, why doesn't it revert? Essentially, it can't. It's a 3-nuc mutation & L61D would require two extremely rare nuc mutations. I've seen just one case of a ORF6:L61D reversion that appeared genuine.
11/15
11/15
July 16, 2026 at 3:55 PM
So if ORF6:D61L is a harmful mutation, why doesn't it revert? Essentially, it can't. It's a 3-nuc mutation & L61D would require two extremely rare nuc mutations. I've seen just one case of a ORF6:L61D reversion that appeared genuine.
11/15
11/15
India 5 COVID-19 brain autopsies and human neuron cultures reveal that SARS-CoV-2 Orf6 hijacks the mitochondrial protein MTCH1, causing oxidative stress and necroptosis, a pathway that may underlie long COVID brain fog.
www.researchsquare.com/article/rs-7...
www.researchsquare.com/article/rs-7...
SARS-CoV-2 Orf6 Triggers MTCH1-Dependent Mitochondrial Dysfunction and Necroptosis in Human Neurons
The molecular basis of neuronal damage in SARS-CoV-2 infection remains elusive. Here, we identify the viral accessory protein Orf6 as a key driver of necroptotic neuronal death. Through a systematic s...
www.researchsquare.com
September 8, 2025 at 3:37 PM
India 5 COVID-19 brain autopsies and human neuron cultures reveal that SARS-CoV-2 Orf6 hijacks the mitochondrial protein MTCH1, causing oxidative stress and necroptosis, a pathway that may underlie long COVID brain fog.
www.researchsquare.com/article/rs-7...
www.researchsquare.com/article/rs-7...
Antagonisten ORF6 und Nukleokapsid, was an die VOCs Alpha bis Delta erinnert. Erhöhte ORF6-Spiegel unterdrückten die angeborene Reaktion des Wirts auf die Infektion, indem sie die IRF3- und STAT1-Signalübertragung verringerten.
January 23, 2024 at 2:36 PM
Antagonisten ORF6 und Nukleokapsid, was an die VOCs Alpha bis Delta erinnert. Erhöhte ORF6-Spiegel unterdrückten die angeborene Reaktion des Wirts auf die Infektion, indem sie die IRF3- und STAT1-Signalübertragung verringerten.
Just throwing this out there in case someone might be interested in testing the BA.3.2 ORF6, which might give us additional understanding of its penchant for kids, or ORF6:P57S in a D61L context, which could provide insight into the dynamics of chronic infections.
15/end
15/end
July 16, 2026 at 3:55 PM
Just throwing this out there in case someone might be interested in testing the BA.3.2 ORF6, which might give us additional understanding of its penchant for kids, or ORF6:P57S in a D61L context, which could provide insight into the dynamics of chronic infections.
15/end
15/end
ohne Apoptose, Pyroptose oder Autophagie auszulösen. Diese Ergebnisse wurden in SARS-CoV-2-infizierten Neuronen und in Hippocampus-Hirnschnitten von COVID-19-Patienten bestätigt, bei denen erhöhte Nekroptose-Marker beobachtet wurden. Mechanistisch wurde festgestellt, dass Orf6
September 10, 2025 at 9:38 PM
ohne Apoptose, Pyroptose oder Autophagie auszulösen. Diese Ergebnisse wurden in SARS-CoV-2-infizierten Neuronen und in Hippocampus-Hirnschnitten von COVID-19-Patienten bestätigt, bei denen erhöhte Nekroptose-Marker beobachtet wurden. Mechanistisch wurde festgestellt, dass Orf6
Akzessorische Proteine (ORF3a, ORF6, ORF7a, ORF7b, ORF8, ORF9b und möglicherweise andere) scheinen hauptsächlich an der Immunevasion beteiligt zu sein. ORF6 hemmt selektiv den nuklearen
Transport des Wirts-Transkriptionsfaktors,
Transport des Wirts-Transkriptionsfaktors,
January 23, 2024 at 2:40 PM
Akzessorische Proteine (ORF3a, ORF6, ORF7a, ORF7b, ORF8, ORF9b und möglicherweise andere) scheinen hauptsächlich an der Immunevasion beteiligt zu sein. ORF6 hemmt selektiv den nuklearen
Transport des Wirts-Transkriptionsfaktors,
Transport des Wirts-Transkriptionsfaktors,
First, BA.3.2—saltation variant from ~3-year chronic infection—is the first variant since BA.5 to lack ORF6:D61L. Instead, it gets D61H + an LNEQT extension.
This has been entirely overlooked, including by me.
Does this restore ORF6's powers—or further cripple them?
2/15
This has been entirely overlooked, including by me.
Does this restore ORF6's powers—or further cripple them?
2/15
July 16, 2026 at 3:55 PM
First, BA.3.2—saltation variant from ~3-year chronic infection—is the first variant since BA.5 to lack ORF6:D61L. Instead, it gets D61H + an LNEQT extension.
This has been entirely overlooked, including by me.
Does this restore ORF6's powers—or further cripple them?
2/15
This has been entirely overlooked, including by me.
Does this restore ORF6's powers—or further cripple them?
2/15
The C-terminal domain (CTD) of ORF6 is essential for its function, & BA.3.2 has an entirely different ORF6 CTD than previous variants. The 61st residue is H instead of D (ancestral, BA.5) or L (BA.2, BA.4, XBB, JN.1). And it adds an extra LNEQT after that.
No one has any idea what effect this has.
No one has any idea what effect this has.
April 23, 2026 at 11:58 PM
The C-terminal domain (CTD) of ORF6 is essential for its function, & BA.3.2 has an entirely different ORF6 CTD than previous variants. The 61st residue is H instead of D (ancestral, BA.5) or L (BA.2, BA.4, XBB, JN.1). And it adds an extra LNEQT after that.
No one has any idea what effect this has.
No one has any idea what effect this has.
SARS-CoV-2 Orf6 Protein Found to Kill Human Brain Cells by Damaging Mitochondria
www.thailandmedical.news/news/sars-co...
www.thailandmedical.news/news/sars-co...
SARS-CoV-2 Orf6 Protein Found to Kill Human Brain Cells by Damaging Mitochondria - Thailand Medical News
www.thailandmedical.news
September 9, 2025 at 1:58 AM
SARS-CoV-2 Orf6 Protein Found to Kill Human Brain Cells by Damaging Mitochondria
www.thailandmedical.news/news/sars-co...
www.thailandmedical.news/news/sars-co...
But where reversions are rare or difficult, nearby mutations can often compensate for the harmful effects of the original mutation. I think one example of this is likely ORF6:P57S. It's the only common ORF6 substitution that's distinctly overrepresented in chronic-infection sequence.
12/15
12/15
July 16, 2026 at 3:55 PM
But where reversions are rare or difficult, nearby mutations can often compensate for the harmful effects of the original mutation. I think one example of this is likely ORF6:P57S. It's the only common ORF6 substitution that's distinctly overrepresented in chronic-infection sequence.
12/15
12/15
So we don't know what BA.3.2's ORF6—with its 5-AA extension—can do, but we do know it might be very different from the prevailing ORF6:D61L variety given the large and opposing effects of adding or removing just a 2-AA extension.
6/15
6/15
July 16, 2026 at 3:55 PM
So we don't know what BA.3.2's ORF6—with its 5-AA extension—can do, but we do know it might be very different from the prevailing ORF6:D61L variety given the large and opposing effects of adding or removing just a 2-AA extension.
6/15
6/15
Protein Orf6 direkt mit dem mitochondrialen Wirtsprotein Mitochondrial Carrier Homolog 1 (MTCH1) interagiert, um diesen Prozess zu vermitteln. Diese Ergebnisse bieten eine mechanistische Erklärung für die SARS-CoV-2-induzierte
September 10, 2025 at 9:37 PM
Protein Orf6 direkt mit dem mitochondrialen Wirtsprotein Mitochondrial Carrier Homolog 1 (MTCH1) interagiert, um diesen Prozess zu vermitteln. Diese Ergebnisse bieten eine mechanistische Erklärung für die SARS-CoV-2-induzierte
ORF6's tail is key for binding to the nuclear pore & shutting it down. Negative charge (D's & E's) is crucial for this, which is why loss of the C-terminal D inhibits its function.
BA.3.2 lacks D61 but adds an E three sites down. Might this restore ORF6's powers? Or does it further inhibit it?
3/15
BA.3.2 lacks D61 but adds an E three sites down. Might this restore ORF6's powers? Or does it further inhibit it?
3/15
July 16, 2026 at 3:55 PM
ORF6's tail is key for binding to the nuclear pore & shutting it down. Negative charge (D's & E's) is crucial for this, which is why loss of the C-terminal D inhibits its function.
BA.3.2 lacks D61 but adds an E three sites down. Might this restore ORF6's powers? Or does it further inhibit it?
3/15
BA.3.2 lacks D61 but adds an E three sites down. Might this restore ORF6's powers? Or does it further inhibit it?
3/15
Why didn't BA.4 evolve to revert to ORF6:61D or reverse the ORF1a:∆141-143 deletion? Because these mutations are extremely unlikely.
ORF6:D61L is a 3-nuc mutation & the first 2 would have to revert to get back to D61. Both involve very rare nuc muts: C→G (the rarest) and T→A (3rd-rarest). 8/10
ORF6:D61L is a 3-nuc mutation & the first 2 would have to revert to get back to D61. Both involve very rare nuc muts: C→G (the rarest) and T→A (3rd-rarest). 8/10
June 29, 2025 at 4:46 PM
Why didn't BA.4 evolve to revert to ORF6:61D or reverse the ORF1a:∆141-143 deletion? Because these mutations are extremely unlikely.
ORF6:D61L is a 3-nuc mutation & the first 2 would have to revert to get back to D61. Both involve very rare nuc muts: C→G (the rarest) and T→A (3rd-rarest). 8/10
ORF6:D61L is a 3-nuc mutation & the first 2 would have to revert to get back to D61. Both involve very rare nuc muts: C→G (the rarest) and T→A (3rd-rarest). 8/10
zuvor mit Coronavirus-Infektionen in Verbindung gebracht wurde, ist diese Studie die erste, die speziell Nekroptose in menschlichen Neuronen als Reaktion auf SARS-CoV-2 identifiziert und diese Ergebnisse im Hirngewebe von Patienten validiert.
September 10, 2025 at 9:40 PM
zuvor mit Coronavirus-Infektionen in Verbindung gebracht wurde, ist diese Studie die erste, die speziell Nekroptose in menschlichen Neuronen als Reaktion auf SARS-CoV-2 identifiziert und diese Ergebnisse im Hirngewebe von Patienten validiert.
Some sarbecos (e.g. SARS-1) have a 2-AA extension on ORF6. Removing the extension from SARS-1 enormously increases its NPC binding, but adding it to SARS-2 ORF6 slight increases its binding.
So we know C-terminal extensions can have a large effect, but in complex, hard-to-predict ways.
5/15
So we know C-terminal extensions can have a large effect, but in complex, hard-to-predict ways.
5/15
July 16, 2026 at 3:55 PM
Some sarbecos (e.g. SARS-1) have a 2-AA extension on ORF6. Removing the extension from SARS-1 enormously increases its NPC binding, but adding it to SARS-2 ORF6 slight increases its binding.
So we know C-terminal extensions can have a large effect, but in complex, hard-to-predict ways.
5/15
So we know C-terminal extensions can have a large effect, but in complex, hard-to-predict ways.
5/15
Durch ein systematisches Screening von 22 SARS-CoV-2-Proteinen stellte sich in dieser Studie heraus, dass Orf6 die größte Zytotoxizität für menschliche Zellen aufweist. In Neuronen schaltete es den Nekroptoseschalter ein – RIPK3 und MLKL. Biologisch gesehen schlagen
September 10, 2025 at 9:34 PM
Durch ein systematisches Screening von 22 SARS-CoV-2-Proteinen stellte sich in dieser Studie heraus, dass Orf6 die größte Zytotoxizität für menschliche Zellen aufweist. In Neuronen schaltete es den Nekroptoseschalter ein – RIPK3 und MLKL. Biologisch gesehen schlagen
direkt mit dem mitochondrialen Membranprotein MTCH1 interagiert und eine mitochondriale Kalziumüberladung, einen Verlust des Membranpotentials und oxidativen Stress auslöst. Wenn MTCH1 stummgeschaltet oder RIPK3 blockiert wurde, überlebten die Neuronen.
Während Nekroptose bereits
Während Nekroptose bereits
September 10, 2025 at 9:39 PM
direkt mit dem mitochondrialen Membranprotein MTCH1 interagiert und eine mitochondriale Kalziumüberladung, einen Verlust des Membranpotentials und oxidativen Stress auslöst. Wenn MTCH1 stummgeschaltet oder RIPK3 blockiert wurde, überlebten die Neuronen.
Während Nekroptose bereits
Während Nekroptose bereits